Outlook Therapeutics, Inc. - COM NEW (OTLK)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / COM NEW
Number of holders
72
Total Shares
24M
Shares change
-768K
Total reported value, excl. options
$29.3M
Value change
-$913K
Put/Call ratio
0
Number of buys
31
Number of sells
-20
Price
$1.22
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.